{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Science Desk", "lead_paragraph": "In the Star Trek movie ''The Voyage Home,'' about a visit to present-day Earth from the future, Dr. McCoy sneaks into a hospital to rescue the injured Chekov and views with horror the barbarous implements of 20th-century medicine, the gross knives and saws so unsuited for the delicate soft machinery they are intended to repair. With the new tools of genomics and stem cell biology, some biologists hope to develop a set of novel treatments that may not seem so alien to visitors from three centuries ahead. ''Regenerative medicine,'' as some call it, would depend not on scalpels and poisons but on the same agents the body itself uses to repair its own fabric -- cells and chemical signals.", "headline": {"main": "Teaching the Body To Heal Itself; Work on Cells' Signals Fosters Talk of a New Medicine"}, "abstract": "Regenerative medicine--teaching the body to heal itself and to grow new tissues and organs--is merely a concept for now, but its prospects look brighter with the tools of genomics and stem cell biology; there have been notable advances in understanding how the body repairs itself, especially its cell-to-cell signaling system; photos; drawings (L)", "print_page": "1", "word_count": 3491, "_id": "4fd240e88eb7c8105d7d91a7", "snippet": "In the Star Trek movie ''The Voyage Home,'' about a visit to present-day Earth from the future, Dr. McCoy sneaks into a hospital to rescue the injured Chekov and views with horror the barbarous implements of 20th-century medicine, the gross knives...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2000/11/07/science/teaching-body-heal-itself-work-cells-signals-fosters-talk-new-medicine.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "STEM CELLS"}, {"name": "subject", "value": "GENETICS AND HEREDITY"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Nicholas", "lastname": "WADE"}], "original": "By NICHOLAS WADE"}, "document_type": "article", "pub_date": "2000-11-07T00:00:00Z", "section_name": "Science; Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "When executives and lobbyists from the biotechnology industry visit Capitol Hill these days, they are often given unsolicited advice: distance yourselves, they are told, from big pharmaceutical companies, which have become public villains in the debate over rising drug prices. Representative Bill Thomas, the California Republican who is chairman of the House Ways and Means health subcommittee, even told biotechnology executives to pick a public fight with ''Big Pharma'' on a prominent issue, according to industry executives who met with him.", "headline": {"main": "Protecting a Favorable Image; Biotechnology Concerns in Quandary Over Drug Giants"}, "abstract": "Drug industry, fearing government regulation of prescription drug prices, has spent heavily lately to influence candidates, legislators and general public; big pharmaceutical companies would like to enlist more politically appealing biotechnology companies in their fight against Medicare drug prescription benefit that they say would eventually lead to price controls on drugs; drug industry, in effort to overcome its tarnished position, has spent $230 million in last two years on lobbying, image advertising and campaign contributions; Repr Bill Thomas, California Republican and chairman of House Ways and Means health subcommittee, is urging biotechnology executives to pick fight with giant drug companies; graphs; photos (M)", "print_page": "1", "word_count": 1477, "_id": "4fd20bc28eb7c8105d77a812", "snippet": "When executives and lobbyists from the biotechnology industry visit Capitol Hill these days, they are often given unsolicited advice: distance yourselves, they are told, from big pharmaceutical companies, which have become public villains in the...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2000/11/04/business/protecting-a-favorable-image-biotechnology-concerns-in-quandary-over-drug-giants.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "BUSH, GEORGE W"}, {"name": "persons", "value": "GORE, AL"}, {"name": "persons", "value": "THOMAS, BILL"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "FINANCES"}, {"name": "subject", "value": "ELECTION ISSUES"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "PRESIDENTIAL ELECTION OF 2000"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "REGULATION AND DEREGULATION OF INDUSTRY"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "GENETICS AND HEREDITY"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "ELECTIONS"}, {"name": "subject", "value": "LOBBYING AND LOBBYISTS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2000-11-04T00:00:00Z", "section_name": "Health; Business"}], "meta": {"hits": 2, "offset": 0, "time": 30}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}